List of Excipients in API PALONOSETRON HYDROCHLORIDE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing PALONOSETRON HYDROCHLORIDE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Accord Healthcare Inc | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | 16729-365 | CITRIC ACID MONOHYDRATE | |
| Accord Healthcare Inc | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | 16729-365 | EDETATE DISODIUM | |
| Accord Healthcare Inc | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | 16729-365 | MANNITOL | |
| Accord Healthcare Inc | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | 16729-365 | SODIUM CITRATE | |
| Accord Healthcare Inc | PALONOSETRON HYDROCHLORIDE | palonosetron hydrochloride | 16729-365 | WATER | |
| Eisai Inc | ALOXI | palonosetron hydrochloride | 62856-797 | CITRIC ACID MONOHYDRATE | |
| Eisai Inc | ALOXI | palonosetron hydrochloride | 62856-797 | EDETATE DISODIUM | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing PALONOSETRON HYDROCHLORIDE
Detailed excipient profiles for PALONOSETRON HYDROCHLORIDE
Excipient focus: BUTYLATED HYDROXYANISOLE
PALONOSETRON HYDROCHLORIDE drug variants containing BUTYLATED HYDROXYANISOLE
| Company | Ingredient | NDC |
|---|---|---|
| Helsinn Therapeutics (US) Inc | palonosetron hydrochloride | 69639-104 |
| >Company | >Ingredient | >NDC |
PALONOSETRON HYDROCHLORIDE drug variants not containing BUTYLATED HYDROXYANISOLE
Excipient focus: CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
PALONOSETRON HYDROCHLORIDE drug variants containing CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Helsinn Therapeutics (US) Inc | palonosetron hydrochloride | 69639-104 |
| >Company | >Ingredient | >NDC |
PALONOSETRON HYDROCHLORIDE drug variants not containing CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
Excipient focus: CITRIC ACID MONOHYDRATE
PALONOSETRON HYDROCHLORIDE drug variants containing CITRIC ACID MONOHYDRATE
PALONOSETRON HYDROCHLORIDE drug variants not containing CITRIC ACID MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | palonosetron hydrochloride | 50742-485 |
| Helsinn Therapeutics (US) Inc | palonosetron hydrochloride | 69639-104 |
| >Company | >Ingredient | >NDC |
Excipient focus: EDETATE DISODIUM
PALONOSETRON HYDROCHLORIDE drug variants containing EDETATE DISODIUM
PALONOSETRON HYDROCHLORIDE drug variants not containing EDETATE DISODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Apotex Corp | palonosetron hydrochloride | 60505-6193 |
| Qilu Pharmaceutical Co Ltd | palonosetron hydrochloride | 67184-0514 |
| BluePoint Laboratories | palonosetron hydrochloride | 68001-482 |
| Helsinn Therapeutics (US) Inc | palonosetron hydrochloride | 69639-104 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERIN
PALONOSETRON HYDROCHLORIDE drug variants containing GLYCERIN
| Company | Ingredient | NDC |
|---|---|---|
| Helsinn Therapeutics (US) Inc | palonosetron hydrochloride | 69639-104 |
| >Company | >Ingredient | >NDC |
PALONOSETRON HYDROCHLORIDE drug variants not containing GLYCERIN
Excipient focus: GLYCINE
PALONOSETRON HYDROCHLORIDE drug variants containing GLYCINE
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | palonosetron hydrochloride | 50742-485 |
| >Company | >Ingredient | >NDC |
PALONOSETRON HYDROCHLORIDE drug variants not containing GLYCINE
Excipient focus: HYDROCHLORIC ACID
PALONOSETRON HYDROCHLORIDE drug variants containing HYDROCHLORIC ACID
PALONOSETRON HYDROCHLORIDE drug variants not containing HYDROCHLORIC ACID
Excipient focus: MANNITOL
PALONOSETRON HYDROCHLORIDE drug variants containing MANNITOL
PALONOSETRON HYDROCHLORIDE drug variants not containing MANNITOL
| Company | Ingredient | NDC |
|---|---|---|
| Helsinn Therapeutics (US) Inc | palonosetron hydrochloride | 69639-104 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYGLYCERYL-10 OLEATE
PALONOSETRON HYDROCHLORIDE drug variants containing POLYGLYCERYL-10 OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Helsinn Therapeutics (US) Inc | palonosetron hydrochloride | 69639-104 |
| >Company | >Ingredient | >NDC |
PALONOSETRON HYDROCHLORIDE drug variants not containing POLYGLYCERYL-10 OLEATE
Excipient focus: SODIUM CITRATE
PALONOSETRON HYDROCHLORIDE drug variants containing SODIUM CITRATE
PALONOSETRON HYDROCHLORIDE drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
PALONOSETRON HYDROCHLORIDE drug variants containing SODIUM HYDROXIDE
PALONOSETRON HYDROCHLORIDE drug variants not containing SODIUM HYDROXIDE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
PALONOSETRON HYDROCHLORIDE drug variants containing TRISODIUM CITRATE DIHYDRATE
PALONOSETRON HYDROCHLORIDE drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
PALONOSETRON HYDROCHLORIDE drug variants containing WATER
PALONOSETRON HYDROCHLORIDE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Ingenus Pharmaceuticals LLC | palonosetron hydrochloride | 50742-485 |
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
